Back to courses
Science beginner

Psychedelic Therapy Johns Hopkins

Duration0 hours
Modules7
ForGeneral public, lifelong learners
Video1-2min
Get started — free →

Course outline

Module 1 Module 1: Introduction to Psychedelic Therapy

Introduction to Psychedelic Therapy

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. What is the primary focus of psychedelic therapy?
  • A. To induce hallucinations for entertainment
  • B. To explore and heal psychological issues through altered states of consciousness ✓
  • C. To replace traditional therapy methods
  • D. To enhance sensory perception

Why: Psychedelic therapy focuses on using psychedelics to explore and heal psychological issues by facilitating altered states of consciousness that can lead to insight and emotional processing.

Q2. Which of the following is a common psychedelic substance used in therapeutic settings?
  • A. Caffeine
  • B. LSD ✓
  • C. Aspirin
  • D. Alcohol

Why: LSD is a common psychedelic substance used in therapeutic settings under controlled and clinical conditions.

Q3. Which institution is known for pioneering research in psychedelic therapy?
  • A. Harvard University
  • B. Johns Hopkins University ✓
  • C. Stanford University
  • D. MIT

Why: Johns Hopkins University is well known for its pioneering research in psychedelic therapy, particularly in the study of psilocybin and its therapeutic potential.

Q4. What is a potential benefit of psychedelic therapy for patients with depression?
  • A. It increases physical strength
  • B. It can lead to profound emotional insights and relief from symptoms ✓
  • C. It reduces the need for sleep
  • D. It enhances memory retention

Why: A potential benefit of psychedelic therapy for patients with depression is that it can lead to profound emotional insights and relief from symptoms through the exploration of inner experiences.

Q5. What is a key component of preparation before a psychedelic therapy session?
  • A. Consuming a large meal
  • B. Setting clear intentions and discussing expectations with a therapist ✓
  • C. Avoiding all social interaction
  • D. Taking a long nap

Why: A key component of preparation before a psychedelic therapy session is setting clear intentions and discussing expectations with a therapist to ensure a safe and meaningful experience.

Module 2 Module 2: History and Ethics of Psychedelic Use

History and Ethics of Psychedelic Use

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. Which of the following was a key figure in the early research on psychedelic substances at the Johns Hopkins University?
  • A. Albert Hofmann
  • B. Rick Doblin ✓
  • C. Timothy Leary
  • D. Stanislav Grof

Why: Rick Doblin is a key figure associated with the early research on psychedelic substances at Johns Hopkins University, particularly through his work with the Multidisciplinary Association for Psychedelic Studies (MAPS).

Q2. In which decade did the use of psychedelics in therapeutic settings begin to decline in the United States?
  • A. 1950s
  • B. 1960s ✓
  • C. 1970s
  • D. 1980s

Why: The use of psychedelics in therapeutic settings began to decline in the United States during the 1960s due to increasing public concern, media portrayal, and the rise of the counterculture movement.

Q3. Which of the following is a primary ethical consideration in psychedelic therapy?
  • A. Cost of treatment
  • B. Informed consent ✓
  • C. Availability of drugs
  • D. Patient age

Why: Informed consent is a primary ethical consideration in psychedelic therapy, ensuring that participants are fully aware of the potential risks and benefits of the treatment.

Q4. Which psychedelic substance was first synthesized by Albert Hofmann in 1938?
  • A. LSD ✓
  • B. Psilocybin
  • C. MDMA
  • D. Ayahuasca

Why: LSD was first synthesized by Albert Hofmann in 1938 while he was working at Sandoz Laboratories.

Q5. What is the name of the organization that has been instrumental in promoting the ethical use of psychedelics in research and therapy?
  • A. Johns Hopkins University
  • B. MAPS ✓
  • C. NIDA
  • D. WHO

Why: MAPS (Multidisciplinary Association for Psychedelic Studies) has been instrumental in promoting the ethical use of psychedelics in research and therapy.

Module 3 Module 3: Neuroscience of Psychedelics

Neuroscience of Psychedelics

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. What is the primary neurotransmitter system affected by psychedelics?
  • A. Dopamine
  • B. Serotonin ✓
  • C. Acetylcholine
  • D. GABA

Why: Psychedelics primarily affect the serotonin system, particularly the 5-HT2A receptor.

Q2. Which brain region is heavily involved in the effects of psychedelics, especially in altering perception and mood?
  • A. Amygdala
  • B. Prefrontal cortex ✓
  • C. Hippocampus
  • D. Thalamus

Why: The prefrontal cortex is heavily involved in the effects of psychedelics, especially in altering perception and mood.

Q3. Which psychedelic is most commonly studied in neuroscience research?
  • A. LSD
  • B. MDMA
  • C. Psilocybin ✓
  • D. Ayahuasca

Why: Psilocybin is one of the most commonly studied psychedelics in neuroscience research.

Q4. What effect do psychedelics have on the default mode network (DMN)?
  • A. They increase activity in the DMN
  • B. They decrease activity in the DMN
  • C. They have no effect on the DMN
  • D. They temporarily disconnect the DMN ✓

Why: Psychedelics temporarily disconnect the default mode network, which is associated with self-referential thought and ego.

Q5. Which receptor is most commonly associated with the hallucinogenic effects of psychedelics?
  • A. Dopamine receptor
  • B. Serotonin 5-HT2A receptor ✓
  • C. Glutamate receptor
  • D. GABA receptor

Why: The serotonin 5-HT2A receptor is most commonly associated with the hallucinogenic effects of psychedelics.

Module 4 Module 4: Therapeutic Applications of Psychedelics

Therapeutic Applications of Psychedelics

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. What is a primary therapeutic application of psychedelics in clinical settings?
  • A. Enhancing physical strength
  • B. Treating mental health disorders ✓
  • C. Improving memory retention
  • D. Increasing lifespan

Why: Psychedelics are primarily used in clinical settings to treat mental health disorders such as depression, PTSD, and anxiety.

Q2. Which psychedelic substance has been most extensively studied for therapeutic use at Johns Hopkins?
  • A. LSD
  • B. Psilocybin ✓
  • C. MDMA
  • D. Ayahuasca

Why: Psilocybin has been most extensively studied for therapeutic use at Johns Hopkins, particularly in the treatment of depression and end-of-life anxiety.

Q3. What is a common setting for psychedelic-assisted therapy?
  • A. Outdoor hiking trails
  • B. A quiet, controlled environment ✓
  • C. A crowded party
  • D. A noisy street

Why: A quiet, controlled environment is a common setting for psychedelic-assisted therapy to ensure safety and facilitate the therapeutic process.

Q4. What is a potential benefit of using psychedelics in therapy?
  • A. Reducing the need for sleep
  • B. Promoting emotional insight and healing ✓
  • C. Increasing appetite
  • D. Enhancing physical coordination

Why: A potential benefit of using psychedelics in therapy is promoting emotional insight and healing, which can lead to long-term mental health improvements.

Q5. Which of the following is a key component of psychedelic therapy?
  • A. Alcohol consumption
  • B. Guided psychological support ✓
  • C. Isolation from others
  • D. Physical exercise

Why: Guided psychological support is a key component of psychedelic therapy, providing a safe and structured environment for the experience.

Module 5 Module 5: Integration and Aftercare Processes

Integration and Aftercare Processes

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. What is the primary goal of integration in psychedelic therapy?
  • A. To achieve immediate psychological healing
  • B. To help individuals process and incorporate insights into daily life ✓
  • C. To replace traditional therapy methods
  • D. To enhance the hallucinogenic experience

Why: Integration is the process of making sense of and incorporating the insights and experiences gained during a psychedelic session into everyday life, which is essential for long-term psychological growth.

Q2. Which of the following is NOT a common component of aftercare in psychedelic therapy?
  • A. Follow-up sessions with the therapist
  • B. Group support meetings
  • C. Complete isolation from social interactions ✓
  • D. Mindfulness and self-care practices

Why: Aftercare typically involves continued support through therapy, group meetings, and self-care, but isolation is not recommended and can be detrimental to the integration process.

Q3. What role does the therapist play during the integration phase?
  • A. To prescribe additional psychedelic doses
  • B. To guide the individual in reflecting on the experience and applying insights ✓
  • C. To ensure the individual remains in a trance-like state
  • D. To replace the individual's support system

Why: The therapist's role during integration is to help the individual process their experience, reflect on insights, and apply them to their life in a meaningful way.

Q4. Which of the following is a potential challenge during the integration process?
  • A. Decreased motivation
  • B. Increased self-awareness

Why: Decreased motivation can be a challenge during integration, as individuals may struggle with applying new insights or dealing with emotional discomfort that arises from the process.

Q5. What is a key benefit of having a structured aftercare plan following psychedelic therapy?
  • A. It ensures the individual never experiences any emotional distress again
  • B. It provides ongoing support and reduces the risk of relapse into old patterns ✓
  • C. It eliminates the need for any further therapy sessions
  • D. It guarantees a complete transformation of the individual's personality

Why: A structured aftercare plan helps individuals maintain the progress made during therapy, provides ongoing support, and reduces the risk of reverting to previous behavioral or thought patterns.

Module 6 Module 6: Clinical Research and Safety Protocols

Clinical Research and Safety Protocols

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. What is the primary purpose of informed consent in psychedelic therapy research?
  • A. To ensure participants receive financial compensation
  • B. To ensure participants understand the risks and benefits of the study ✓
  • C. To guarantee the study will be published in a scientific journal
  • D. To ensure the research team is properly trained

Why: Informed consent is a critical ethical and legal requirement that ensures participants are fully aware of the nature, purpose, risks, and benefits of the research before agreeing to participate.

Q2. Which of the following is a common safety protocol used during psychedelic therapy sessions?
  • A. Administering high doses of alcohol
  • B. Providing continuous medical supervision ✓
  • C. Limiting participant communication
  • D. Encouraging solitary meditation

Why: Continuous medical supervision is a standard safety protocol to monitor participants' physiological and psychological responses during psychedelic therapy sessions.

Q3. What is the role of a screening interview in psychedelic therapy research?
  • A. To determine the participant's eligibility for the study ✓
  • B. To provide therapy sessions to participants
  • C. To distribute study materials
  • D. To collect payment from participants

Why: Screening interviews are used to assess a participant's suitability for the study by evaluating their mental and physical health, history, and other relevant factors.

Q4. Which of the following is considered a contraindication for psychedelic therapy?
  • A. Having a positive attitude toward the experience
  • B. A history of severe psychiatric disorders ✓
  • C. Being over the age of 30
  • D. Having a strong interest in spirituality

Why: A history of severe psychiatric disorders, such as bipolar disorder or schizophrenia, is typically considered a contraindication for psychedelic therapy due to potential risks.

Q5. What is the purpose of a follow-up session in psychedelic therapy research?
  • A. To provide additional doses of the psychedelic substance
  • B. To assess the long-term effects of the therapy ✓
  • C. To recruit new participants
  • D. To administer a placebo

Why: Follow-up sessions are used to evaluate the long-term psychological and physiological effects of the therapy and to ensure the participant's well-being after the session.

Module 7 Module 7: Personal Experience and Guided Sessions

Personal Experience and Guided Sessions

Introduction

Core content I

Core content II

Core content III

Summary

Further learning

Knowledge check

Q1. What is a primary goal of guided psychedelic sessions?
  • A. To ensure the participant has a bad experience
  • B. To help the participant explore and process emotions and insights safely ✓
  • C. To make the session as short as possible
  • D. To avoid any emotional or psychological impact

Why: Guided sessions aim to support the participant in a safe and therapeutic environment, facilitating emotional and psychological exploration.

Q2. Which of the following is a common technique used in guided psychedelic sessions?
  • A. Ignoring the participant's emotional responses
  • B. Providing a non-judgmental and supportive presence ✓
  • C. Encouraging the participant to avoid introspection
  • D. Limiting communication to only factual information

Why: A non-judgmental and supportive presence is essential in guided sessions to help the participant feel safe and supported.

Q3. What is the role of the therapist during a psychedelic session?
  • A. To control the participant's thoughts and emotions
  • B. To guide and support the participant without imposing their own interpretations ✓
  • C. To ensure the session follows a strict schedule
  • D. To prevent the participant from having any insights or realizations

Why: The therapist's role is to guide and support the participant, allowing them to explore their own experiences without interference.

Q4. What is a key benefit of incorporating personal experience into guided sessions?
  • A. It increases the likelihood of adverse reactions
  • B. It helps the therapist understand the participant's unique context and history ✓
  • C. It reduces the need for any preparation or planning
  • D. It ensures the session will be identical for all participants

Why: Incorporating personal experience allows the therapist to tailor the session to the participant's specific needs and background.

Q5. What is an important consideration when discussing personal experiences during a psychedelic session?
  • A. Sharing only negative experiences
  • B. Maintaining confidentiality and respecting the participant's boundaries ✓
  • C. Forcing the participant to share all experiences
  • D. Avoiding any emotional expression

Why: Confidentiality and respect for the participant's boundaries are essential to creating a safe and trusting environment.

Stay in the loop on this course.

We’ll email you when new modules or related material drops. No spam.

Built with Fragment Language. Sovereign architecture — no third-party trackers.
FragRun.mfgAFImemoryFGOwnership: B-Systems.ee